Cartesian Therapeutics Inc. (RNAC) Live Share Price, Invest From India

Cartesian Therapeutics Inc. Stock Performance

as on May 6, 2026 at 6:59 am IST

Day's Low
Day's High
$6.83
Day's Price Range
$7.40
$7.39
7.58%
Downside
0.14%
Upside
52 Week's Low
52 Week's High
$5.60
52-Week Price Range
$15.57
$7.39
24.22%
Downside
110.69%
Upside

Cartesian Therapeutics Inc. share price movements today

Previous Close: $6.93
Open: $7.01
Volume: 387.7K
Day's Low - High: $6.83 - $7.40
52 Week Low - High: $5.60 - $15.57

Cartesian Therapeutics Inc. Historical Returns

1 Month Return: + 11.06 %
3 Month Return: + 6.78 %
1 Year Return: -34.44 %
3 Year Return: 0 %
5 Year Return: 0 %

Cartesian Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Cartesian Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$182.3M

EPS (TTM)

-3.01

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.07%

PE Ratio (TTM)

PEG Ratio

EBITDA

-88.9M

Revenue (TTM)

1.8M

Profit Margin

0.00%

Return On Equity TTM

-7029.26%

Cartesian Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cartesian Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cartesian Therapeutics Inc.	BUY	$182.3M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.8B	125.53%	74.67	12.55%
Vertex Pharmaceuticals Inc	BUY	$109.3B	101.66%	27.7	32.94%
BeiGene, Ltd.	NA	$33.0B	NA	118.86	5.37%
Regeneron Pharmaceuticals Inc	BUY	$73.5B	42.22%	17.12	29.65%

Stock Returns calculator for Cartesian Therapeutics Inc. Stock including INR - Dollar returns

The Cartesian Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cartesian Therapeutics Inc. investment value today

Current value as on today

₹79,026

Returns

-₹20,974

(-20.97%)

Returns from Cartesian Therapeutics Inc. Stock

-₹30,085 (-30.09%)

Dollar Impact

₹9,112 (+9.11%)

Analyst Recommendation on Cartesian Therapeutics Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Cartesian Therapeutics Inc.. Average target price of $35.57

Cartesian Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Cartesian Therapeutics Inc..

What analysts predicted

79.22%UPSIDE

Target Price

$35.57

Current Price

$7.39

Analyzed by

11 Analysts

Target

$35.57

Cartesian Therapeutics Inc. target price $35.57, a slight upside of 79.22% compared to current price of $7.39. According to 11 analysts rating.

Cartesian Therapeutics Inc. Stock’s Investor Sentiment and Interest

Search interest for Cartesian Therapeutics Inc. Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 6, 2026 to May 6, 2026

Change:-33% versus previous 30 day period

Cartesian Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	8	5	33	0	0	1	0	0	0	0
Gross Profit	8	5	33	0	0	1	0	-12	0	0
Operating Income	-36	-13	13	-17	-26	-21	-21	-21	-21	-26
EBITDA	-196	-13	13	-23	-9	-20	16	-35	-21	-26
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	1	0	0	0	0
Income Before Tax	-196	-56	13	-24	-9	-17	15	-35	-101	-39
Income Tax Expense	-19	0	0	-	0	-	-	-	-9	-
Net Income	-177	-56	13	-24	-10	-17	15	-35	-92	-39
Net Profit Margin	-2149.26%	-973.01%	41.37%	-6248.84%	1350.86%	-1610.00%	5330.87%	-7942.92%	-9775.71%	-50233.33%

Cartesian Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	8	0	0	6	16	85	110	26	38	2
Gross Profit	8	0	0	6	16	85	108	26	38	2
Operating Income	-34	-63	-65	-52	-56	-4	14	-86	-43	-86
EBITDA	-34	-63	-62	-51	-65	-5	39	-235	-75	-86
Interest Expense	1	1	1	1	1	2	3	2	-	-
Depreciation	-	0	0	2	0	1	1	0	1	2
Income Before Tax	-36	-65	-65	-55	-68	-9	34	-238	-77	-139
Income Tax Expense	0	0	0	1	1	15	0	-19	0	-9
Net Income	-36	-65	-65	-55	-68	-25	35	-219	-77	-130
Net Profit Margin	-447.98%	-31556.04%	-7235.44%	-828.97%	-414.99%	-30.19%	31.94%	-844.91%	-198.97%	-4658.63%

Cartesian Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-56	13	-24	-10	-17	15	-35	-92	-39
Operating Cash Flow	-15	-14	13	-7	-23	-17	-15	-17	-22
Investing Cash Flow	0	-1	-6	0	-1	-2	-1	0	0
Financing Cash Flow	43	0	124	0	-8	0	0	0	15
Change in Cash	26	-15	131	-6	-32	-20	-16	-18	-6

Cartesian Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-65	-65	-55	-68	-25	35	-219	-77	-130
Operating Cash Flow	-52	-59	-51	34	-60	-31	-51	-23	-73
Investing Cash Flow	-2	25	0	0	-17	-15	34	-8	-5
Financing Cash Flow	66	0	105	14	52	39	-13	168	-8
Change in Cash	11	-33	52	48	-24	-7	-29	135	-87

Global Institutional Holdings in Cartesian Therapeutics Inc.

Funds	Holdings
Two Sigma Investments LLC	0.34%
State Street Corp	0.75%
Charles Schwab Investment Management Inc	0.1%
Northern Trust Corp	0.34%
683 Capital Management LLC	0.88%

See all

Insights on Cartesian Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -92.57M → -39.18M (in $), with an average increase of 136.3% per quarter
POSITIVE IMPACT
Price Rise
In the last 3 years, RNAC stock has moved up by 541.7%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, RNAC has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 27.0% return, outperforming this stock by 61.4%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 947.0K → 78.0K (in $), with an average decrease of 91.8% per quarter

About Cartesian Therapeutics Inc.

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, which is in phase 1 trials, an autologous autologous B cell maturation antigen (BCMA) directed mRNA CAR-T to treat patients with multiple myeloma. The company is headquartered in Frederick, Maryland.

Organisation	Cartesian Therapeutics Inc.
Headquarters	7495 New Horizon Way, Frederick, MD, United States, 21703
Industry	Biotechnology
CEO	Dr. Carsten Brunn Ph.D.
E-voting on shares	Click here to vote

Key Management of Cartesian Therapeutics Inc.

Name	Title
Dr. Milos Miljkovic M.D., Ph.D.	Chief Medical Officer
Dr. Emily English Ph.D.	Chief Operating Officer
Ms. June Seymour	Chief Accounting Officer
Mr. Matthew Bartholomae J.D.	General Counsel & Secretary
Dr. Carsten Brunn Ph.D.	President, CEO & Chairman of the Board
Mr. Blaine T. Davis	Chief Financial Officer

FAQs

What is Cartesian Therapeutics Inc. share price today?

Cartesian Therapeutics Inc. share price today is $7.39 as on May 6, 2026 at 1:29 am IST at the close of the market. Cartesian Therapeutics Inc. share today touched a day high of $7.4 and a low of $6.83.

What is the 52 week high and 52 week low for Cartesian Therapeutics Inc. share?

Cartesian Therapeutics Inc. share touched a 52 week high of $15.57 on July 9, 2025 and a 52 week low of $5.6 on March 27, 2026. Cartesian Therapeutics Inc. stock price today i.e. May 6, 2026 at 1:29 am IST is closed at $7.39,which is 52.54% down from its 52 week high and 31.96% up from its 52 week low.

What is Cartesian Therapeutics Inc.'s market capitalisation today?

Cartesian Therapeutics Inc. market capitalisation is $0.00T as on May 6, 2026 at 1:29 am IST.

How to invest in Cartesian Therapeutics Inc. Stock (RNAC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cartesian Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cartesian Therapeutics Inc. Shares that will get you 0.2030 shares as per Cartesian Therapeutics Inc. share price of $7.39 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cartesian Therapeutics Inc. Stock (RNAC) from India?

Indian investors can start investing in Cartesian Therapeutics Inc. (RNAC) shares with as little as ₹95.28 or $1 (as of May 6, 2026 at 6:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Cartesian Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on May 6, 2026 at 6:39 am IST). Based on Cartesian Therapeutics Inc. share’s latest price of $7.39 as on May 6, 2026 at 1:29 am IST, you will get 1.3532 shares of Cartesian Therapeutics Inc.. Learn more about fractional shares .